FDA Inspection 984038 — Neostrata Company Inc

Neostrata Company Inc — FEI 1000121116

The FDA completed an inspection of Neostrata Company Inc on Aug 25, 2016 in Summit, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 25, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Summit, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.